| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.066 | 0.06 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.06 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.06 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.063 | 0.06 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.27 | 0.07 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.07 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.07 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.07 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |